ALFA Filings
Every announcement, straight from the exchange
Every Eiko Lifesciences other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements with these filters
The company submitted the Regulation 74(5) compliance certificate from its Registrar and Share Transfer Agent for the quarter ended September 30, 2026.
Eiko Lifesciences informed exchanges that it sent the AGM notice and Annual Report weblink to shareholders who have not registered email addresses.
This is a routine quarterly shareholding pattern filing for Eiko Lifesciences Ltd for the quarter ended June 30, 2026.
Eiko Lifesciences filed its Annual Secretarial Compliance Report for the year ended March 2026. The auditor confirmed general regulatory compliance with no material adverse observations.
Eiko Lifesciences Limited submitted a certificate under Regulation 74(5) of SEBI Regulations for the quarter ended March 31, 2026. The company’s Registrar, Bigshare Services Pvt. Ltd., confirmed that no dematerialization requests for equity shares were received during this period.